Skip to main content
. 2021 Aug 27;17(6):516–524. doi: 10.4244/EIJ-D-20-01275

Table 3. Management and procedural outcomes.

Patients, n Total Type 1 Type 2A Type 2B Type 3 Type 4 p-value
302 (100) 52 (17.2) 80 (26.5) 69 (22.8) 20 (6.6) 81 (26.8)
Vascular access (n=264) Radial 218 (82.6) 33 (70.2) 54 (79.4) 56 (90.3) 17 (94.4) 58 (84.1) 0.042
Femoral 46 (17.4) 14 (29.8) 14 (20.6) 6 (9.7) 1 (5.6) 11 (15.9) 0.026
Management (first treatment choice) PCI 100 (33.1) 23 (45.1) 18 (22.5) 9 (13) 7 (35) 43 (53.8) <0.001
CABG 4 (1.3) 2 (3.4) 1 (1.3) 1 (1.5) 0 0 0.704
Conservative 198 (65.6) 27 (51) 61 (76.3) 59 (85.5) 13 (65) 37 (46.3) <0.001
PCI (n=100) N=23 N=18 N=9 N=7 N=43
Only guidewire 13 (13) 2 (8.7) 1 (5.6) 2 (22.2) 1 (14.3) 12 (27.9) 0.228
Predilatation 42 (42) 5 (21.7) 8 (44.4) 3 (33.3) 4 (57.1) 22 (51.2) 0.127
Cutting balloon 1 (1) 0 0 0 0 1 1
Stenting* 78 (78) 20 (87) 15 (57.7) 6 (48.2) 6 (85.7) 31 (72.1) 0.248
TIMI flow post procedure 3 78 (78) 19 (82.6) 14 (77.7) 7 (77.8) 7 (100.0) 23 (54.4) 0.004
<3 22 (22) 4 (17.4) 4 (22.2) 2 (22.2) 0 20 (45.6)
Successful PCI Yes 78 (78) 19 (82.6) 17 (94.4) 7 (77.8) 6 (85.7) 29 (67.4) 0.558
Data are presented as means±SDs for continuous variables and numbers (%) for categorical variables. *These include 50 drug-eluting stents, 20 bare metal stents and 8 bioresorbable scaffolds. CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention